425: Strive & Semler Scientific Merger Update

Strive's CRO posted on X.com regarding the proposed business combination with Semler Scientific, reiterating forward-looking statements and regulatory filing details.

Summary

• A communication was posted on X.com by Jeff Walton, Chief Risk Officer of Strive, Inc., on September 25, 2025.
• The communication is in connection with Strive's proposed business combination with Semler Scientific, Inc.
• The filing includes a 'Cautionary Statement Regarding Forward-Looking Statements' outlining inherent risks and uncertainties related to the merger.
• It details where investors can find additional information, including the SEC's website, Strive's and Semler Scientific's websites, and investor relations contacts.
• Strive intends to file a Registration Statement on Form S-4, which will include an Information Statement/Proxy Statement/Prospectus, to register Class A common stock to be issued.
• The communication clarifies that it does not constitute an offer to sell or a solicitation of an offer to buy securities or a solicitation of any vote of approval.

Sentiment

Score: 5

Explanation: The filing is a standard regulatory disclosure for a proposed merger, primarily outlining forward-looking statements and associated risks. It does not contain new positive or negative operational or financial news, maintaining a neutral sentiment.

Positives

• The filing confirms the ongoing progress of the proposed business combination between Strive and Semler Scientific.
• Transparency is provided through detailed cautionary statements and clear instructions on where to access comprehensive merger documents.

Negatives

• No direct negatives in terms of company performance or adverse events are disclosed in this procedural filing.

Risks

• The occurrence of any event, change, or other circumstances that could give rise to the right of one or both parties to terminate the merger agreement.
• The possibility that the proposed transaction does not close when expected or at all because conditions to closing are not received or satisfied on a timely basis or at all.
• The outcome of any legal proceedings that may be instituted against Strive, Semler Scientific, or the combined company.
• Anticipated benefits of the proposed transaction, including cost savings and strategic gains, may not be realized when expected or at all.
• Risks associated with Bitcoin and other digital assets, general economic and market conditions, interest and exchange rates, monetary policy, and laws and regulations and their enforcement, particularly concerning Bitcoin treasury strategies.
• The integration of the two companies may be more difficult, time-consuming, or costly than expected.
• The proposed transaction may be more expensive or take longer to complete than anticipated due to unexpected factors or events.
• Diversion of management's attention from ongoing business operations and opportunities.
• Dilution caused by Strive's issuance of additional shares of its Class A common stock in connection with the proposed transaction.
• Potential adverse reactions of Strive's or Semler Scientific's customers or changes to business or employee relationships resulting from the announcement or completion of the proposed transaction.
• Changes in Strive's or Semler Scientific's share price before closing.
• Other unknown or unpredictable factors could harm Strive, Semler Scientific, or the combined company's results.

Future Outlook

The companies anticipate strategic and financial benefits from the proposed transaction, including a positive impact on the combined company's future financial performance, successful integration of businesses, and timely closing of the transaction. However, these expectations are subject to significant risks and uncertainties.

Management Comments

• Strive and Semler Scientific believe that their expectations with respect to forward-looking statements are based upon reasonable assumptions within the bounds of their existing knowledge of their business and operations.
• Strive and Semler Scientific undertake no obligation to update or clarify these forward-looking statements, whether as a result of new information, future events, or otherwise, except to the extent required by applicable law.

Industry Context

The proposed business combination aligns with ongoing merger and acquisition activity across various sectors. The explicit mention of 'Bitcoin treasury strategies' highlights a growing trend among some companies to explore digital assets for treasury management or investment, reflecting an evolving approach to corporate finance in the digital age.

Corporate Governance

Stakeholder Impact

• Shareholders: Potential dilution from Strive's issuance of additional Class A common stock; requirement to vote on the proposed transaction; potential changes in share price before closing.
• Customers: Potential adverse reactions or changes to business relationships resulting from the announcement or completion of the proposed transaction.
• Employees: Potential changes to employee relationships resulting from the announcement or completion of the proposed transaction.

Next Steps

• Strive intends to file a Registration Statement on Form S-4 with the SEC to register the Class A common stock to be issued.
• The Registration Statement will include an Information Statement/Proxy Statement/Prospectus.
• A definitive Information Statement/Proxy Statement/Prospectus will be sent to the stockholders of Semler Scientific to seek their approval of the proposed transaction.
• Investors and stockholders of Semler Scientific are urged to read the Registration Statement and Information Statement/Proxy Statement/Prospectus when they become available.

Key Dates

Recommendation

The filing is a standard regulatory communication regarding a proposed business combination, primarily serving to disclose forward-looking statements and associated risks. It does not provide new financial performance data or strategic shifts that would alter the fundamental investment thesis for either company at this stage. Investors should hold their positions and await the full Registration Statement on Form S-4 and Information Statement/Proxy Statement/Prospectus for comprehensive details before making further investment decisions.

Keywords

Strive Inc, Semler Scientific, Merger, Acquisition, Business Combination, SEC Filing, Form 425, Bitcoin Treasury Strategy, Corporate Governance, Forward-Looking Statements